Villacrusis, Angelie T.
HRN: 21-77-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2022
CEFUROXIME 500MG (TAB)
10/23/2022
10/23/2022
ORAL
500mg
BID
Thickly Meconium AF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes